F3 and pancreatic neoplasm: We counter-stained with antibodies to Tissue Factor (TF, also known as Factor III), a major determinant of thrombotic risk in pancreatic cancer and often associated with microvesicles in pancreatic cancer patients [66–79], as an indicator of the procoagulant nature of the microvesicle surfaces.